🔎 Trials Near Me

መነሻ › ስቴቶቲክ የጉበት በሽታ › ፍሎሪዳ › Miami

በMiami፣ FL ለስቴቶቲክ የጉበት በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች

ለስቴቶቲክ የጉበት በሽታ የሚደረጉ 16 ጥናቶች በMiami እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • 89bio Clinical Study Site, Miami
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Evolution Clinical Trials, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Miami Health System, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05832229

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Genoma Research Group, Inc., Miami
  • Med Research of Florida, LLC, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Evolution Clinical Trials, Miami
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Akero Clinical Study Site, Miami
  • Akero Clinical Study Site, Miami
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • እና 3 ተጨማሪ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Evolution Clinical Trials, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT07288138

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • GSK Investigational Site, Miami
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • እና 4 ተጨማሪ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • GSK Investigational Site, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
  • Genoma Research Group, Inc, Miami
  • Med Research of Florida, LLC, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT05648214

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Clinical Pharmacology of Miami, Miami
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2025 · NCT07122700

በሌሎች ከተሞች ለስቴቶቲክ የጉበት በሽታ የሚደረጉ ጥናቶች

በMiami ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።